Press Releases

Victory Capital Holdings, Inc. (NASDAQ:VCTR) ("Victory Capital" or the "Company") today reported Total Assets Under Management (AUM) of $356.5 billion, Other Assets of $3.7 billion, and Total Client Assets of $360.2 billion, as of August 31, 2026. For the month of August, Average Total AUM was $353.2 billion, average Other Assets was $3.7 billion, and average Total Client Assets was $356.9 billion. Victory Capital Holdings, Inc. Total Client Assets (unaudited; in millions) 1   As of: By Asset Class August 31, 2026   July 31, 2026 Solutions $ 114,082   $ 108,088 Fixed Income   88,10

Gossamer Bio, Inc. (NASDAQ:GOSS) (the "Company" or "Gossamer"), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease, today announced that it has filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to effect the previously announced 1-for-80 reverse stock split of the Company’s common stock, par value $0.0001 per share, and a proportionate reduction in the number of authorized shares of the Company’s common stock (and a correspon

FICO applauds Federal Housing Administration’s implementation of FICO Score 10T, the most predictive credit score available for mortgage underwritingFICO® Score 10T, the most predictive modern credit score available for mortgage lending, will be available for use by Federal Housing Administration (FHA)-approved lenders beginning January 1, 2027. The availability of FICO® Score 10T will enable lenders to make more accurate lending decisions while helping consumers gain access to more favorable mortgage terms and sustainable homeownership.FICO® Score 10T leverages trended credit and rental payment data to provide a more comprehensive view of borrower behavior over time. Multiple independent an

Glucotrack, Inc. (NASDAQ:GCTK) ("Glucotrack" or the "Company") today announced definitive agreements for convertible notes with an aggregate principal amount of approximately $11.5 million, including approximately $4.5 million of new cash investment and approximately $4.5 million of existing notes being rolled over, with the aggregate principal amount reflecting a 22% original issue discount. The financing is structured as convertible debt with an initial conversion price of $3.12 per share. In connection with the financing, investors will also receive warrants exercisable at $7.50 per share. Dawson James Securities, Inc. acted as Sole Placement Agent for Glucotrack. About Glucotrack, I

Franklin Templeton announced today that certain closed-end funds have declared their distributions for the next three months. Month Record Date Ex-Dividend Date Payable Date September 9/23/2026 9/23/2026 9/30/2026 October 10/23/2026 10/23/2026 10/30/2026 November 11/20/2026 11/20/2026 11/30/2026 Ticker Fund Name Month Amount Change from Previous Distribution PAI Western Asset Investment Grade Income September $0.05250 - Fund Inc. October $0.05250     November $0.05250  

Franklin Templeton announced today that certain closed-end funds have declared distributions pursuant to their managed distribution policy for the next three months. Month Record Date Ex-Dividend Date Payable Date September 9/23/2026 9/23/2026 9/30/2026 October 10/23/2026 10/23/2026 10/30/2026 November 11/20/2026 11/20/2026 11/30/2026 Ticker Fund Name Month Amount Change from Previous Distribution WIA Western Asset Inflation-Linked Income Fund September $0.05200   - October $0.05200    

Up to four selected teams will have their investigations flown to and conducted on the ISS, with Starlab covering access to space. Starlab Space LLC, the commercial space station developer expanding access to low Earth orbit research, and the Center for Space and Aviation Switzerland and Liechtenstein (CSA) who is establishing space as an innovation flagship in the state of Zurich in Switzerland, announced an international Call for Proposals (CFP) for advanced microgravity research and commercialization aboard the International Space Station (ISS). The initiative will provide researchers with funded access to microgravity research opportunities, generating critical data that can advance t

NEW YORK, Sept. 11, 2026 (GLOBE NEWSWIRE) -- NewHold Investment Corp III (NASDAQ:NHIC) ("NewHold") will hold an extraordinary general meeting of its shareholders (the "Extraordinary General Meeting") on September 17, 2026, at 9:00 a.m. Eastern Time, in connection with the previously announced proposed business combination (the "Business Combination") with newcleo plc ("newcleo"), a public limited company incorporated under the laws of England and Wales (f/k/a NewCleo Ltd., a private limited company incorporated under the laws of England and Wales). The Extraordinary General Meeting will be held at the offices of Loeb & Loeb LLP, 345 Park Avenue, New York, NY 10154, and virtually via live

SAN FRANCISCO, CALIFORNIA, Sept. 11, 2026 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the "Company") (NASDAQ:GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE® natural killer (NK) cell engager platform, will host a live company presentation on the development of the TriKE® platform for cancer treatment today, September 11, 2026, at 2:00 p.m. Eastern Time. The webinar will feature Michael Breen, Executive Chairman and Chief Executive Officer of GT Biopharma, and Dr. Jeffrey Miller, MD1, Consulting Senior Medical Director, who will discuss clinical progress in blood cancers and solid tumors, insights from incre

BRISBANE, Calif. , Sept. 11, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (NASDAQ:TPST) (the "Company"), a clinical-stage biotechnology company pioneering the development of advanced in vivo CAR-T therapies for cancer and autoimmune disease, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 3,105,591 shares of common stock (or pre-funded warrant in lieu thereof), series C warrants to purchase up to 3,105,591 shares of common stock and series D warrants to purchase up to 3,105,591 shares of common stock, at a combined purchase price of $0.805 per share of common stock (or per pre-funded warrant in lieu thereof) and accompanyin

  TARPON SPRINGS, Fla., September 11, 2026 – Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ:ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated dual PARP/Wnt pathway inhibitor using its proprietary DRP® technology, announced that Allarity Acquisition Corp., a newly formed special purpose acquisition company (SPAC), has publicly filed a Registration Statement on Form S-1 (the "Registration Statement") with the U.S. Securities and Exchange Commission ("SEC") relating to a proposed initial public offering of its units. The proposed initial public offering is expected to have a base offering size of $100 million, or $115

Hong Kong, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Click Holdings Limited (("Click Holdings" or "Click" or "we" or "us", NASDAQ:CLIK) and its subsidiaries (collectively, the "Company"), a leader in human resources ("HR") and senior care solutions in Hong Kong, today announced that its Chief Executive Officer ("CEO"), Mr. Chan Chun Sing, has purchased 48,200 Class A ordinary shares of the Company in the open market. Purchase Details Mr. Chan acquired a total of 48,200 Class A ordinary shares of Click in the open market. All purchases were made at prevailing market prices, representing an aggregate investment of approximately US$49,900. For full details, please refer to the Form 4 filed with th

OMAHA, Neb., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Exodus Movement, Inc. (NYSE:EXOD) ("Exodus" or the "Company"), a leading self-custodial finance and payments platform, today announced select metrics for the month of August 2026 in connection with its Web3 and Payment Processing services. "August was an encouraging month across both sides of our business," said James Gernetzke, CFO of Exodus. "Our Web3 exchange volumes increased approximately 20% from July as monthly active users remained relatively stable. While we remain cautious about drawing conclusions from one month of improved activity, we are encouraged by the direction of exchange volumes on our platform." "Transaction activity in

Future registration-directed clinical development of efti is intended to focus on head and neck squamous cell carcinoma (HNSCC) in patients with negative PD-L1 expression (Combined Positive Score (CPS) < 1) and the neoadjuvant setting of soft tissue sarcoma (STS).Root cause analysis following the discontinuation of TACTI-004 has identified subtle analytical differences between efti manufactured at 200 L scale and efti manufactured at 2,000 L scale. A new manufacturing run of efti at 200 L scale has been contracted.This development focus reflects a staged risk/benefit approach consistent with prior interactions with the U.S. Food and Drug Administration (FDA), Orphan Drug Designation granted

Virtus Investment Partners, Inc. (NYSE:VRTS) today reported preliminary assets under management (AUM) of $147.5 billion and other fee earning assets of $1.7 billion for total client assets of $149.2 billion as of August 31, 2026. The change in AUM from July 31, 2026, reflects net outflows in institutional accounts, retail separate accounts, U.S. retail funds, and global funds, partially offset by market performance and positive net flows in exchange-traded funds and tender offer funds. Assets Under Management (unaudited) ($ in millions)         By Product Type: August 31, 2026   July 31, 2026 Open-End Funds (1) $

New York, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Columbus Acquisition Corp (the "Company"), a blank check company, today announced that it convened its Extraordinary General Meeting of the Shareholders (the "Meeting") and immediately adjourned the Meeting, without conducting any business. The Meeting was adjourned as to all of the proposals contained in the Company’s definitive proxy statement filed with the Securities and Exchange Commission ("SEC") on August 19, 2026, including any amendments or supplements thereto (the "Proxy Statement"), including the proposal to approve the proposed business combination with WISeSat.Space Corp. The Company will announce the date of the reconvened Meeti

SINGAPORE, Sept. 11, 2026 (GLOBE NEWSWIRE) -- BGIN BLOCKCHAIN LIMITED (("BGIN" or the "Company", NASDAQ:BGIN), a digital asset technology company specializing in proprietary cryptocurrency mining technologies and the manufacturing of cryptocurrency mining hardware, today announced that members of its management team will participate in the H.C. Wainwright 28th Annual Global Investment Conference, to be held September 14–16, 2026, at the Lotte New York Palace Hotel in New York City. Management will also be available for one-on-one meetings with institutional investors during the conference. Investors interested in scheduling a meeting with the Company should contact their H.C. Wainwright r

Scottsdale, AZ, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Black Rock Coffee Bar, the Oregon-born boutique coffee company known for its specialty coffees, teas, smoothies, and popular Fuel® energy drinks, is expanding its footprint in the Valley with a new location opening this week.  The store, located at 3103 S McQueen Rd, will officially celebrate its grand opening in Chandler on Tuesday, September 15th. Guests can enjoy $3 medium drinks all day, with the celebration continuing into the following day with a signature grand opening sticker giveaway. With this opening, Black Rock’s Arizona presence grows to 62 locations, underscoring the brand’s steady expansion throughout the Valley.   "

Vancouver, Canada, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ:CMND) (the "Company"), a clinical-stage biopharmaceutical company advancing non-hallucinogenic psychedelic-derived neuroplastogen for scalable treatment  of neuropsychiatric, metabolic, and addiction disorders including Alcohol Use Disorder ("AUD"), today announced the enrollment of the first patients with Alcohol Use Disorder ("AUD") in its ongoing clinical trial evaluating CMND-100, the Company’s proprietary psychedelic-based treatment candidate for AUD. The first two patients were enrolled at Hadassah Medical Center in Jerusalem, Israel, marking the first time CMND-100 is administered to a patient wi

Scottsdale, AZ, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Black Rock Coffee Bar, the Oregon-born boutique coffee chain celebrated for its specialty coffees, teas, smoothies, and signature Fuel® energy drinks, is growing its footprint in Colorado with the opening of a new store in Highlands Ranch.  The store, located at 9401 S University Blvd, will officially open its doors on Monday, September 14th. This opening marks Black Rock’s twenty-second Colorado location and reinforces the brand’s steady expansion across the region. Guests can enjoy the following specials during opening week:  Monday, 9/14: Free 16oz Drinks  Tuesday, 9/15: Buy One, Get One Free Drinks  Wednesday,